|
1
|
Jiang LY, Lian M, Wang H, Fang JG and Wang
Q: Inhibitory effects of 5-Aza-2-deoxycytidine and trichostatin A
in combination with p53-expressing adenovirus on human
laryngocarcinoma cells. Chin J Cancer Res. 24:232–237. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zuo J, Ishikawa T, Boutros S, Xiao Z,
Humtsoe JO and Kramer RH: Bcl-2 overexpression induces a partial
epithelial to mesenchymal transition and promotes squamous
carcinoma cell invasion and metastasis. Mol Cancer Res. 8:170–182.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang MH and Reynolds CP: Bcl-2 inhibitors:
Targeting mitochondrial apoptotic pathways in cancer therapy. Clin
Cancer Res. 15:1126–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu S, Yu L, Mu Y, Ma J, Tian J, Xu W and
Wang H: Role and mechanism of Twist1 in modulating the
chemosensitivity of FaDu cells. Mol Med Rep. 10:53–60.
2014.PubMed/NCBI
|
|
5
|
Wu M, Zhang H, Hu J, Weng Z, Li C, Li H,
Zhao Y, Mei X, Ren F and Li L: Isoalantolactone inhibits UM-SCC-10A
cell growth via cell cycle arrest and apoptosis induction. PLoS
One. 8:e760002013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rahman MA, Amin AR, Wang D, Koenig L,
Nannapaneni S, Chen Z, Wang Z, Sica G, Deng X, Chen ZG, et al: RRM2
regulates Bcl-2 in head and neck and lung cancers: A potential
target for cancer therapy. Clin Cancer Res. 19:3416–3428. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kawano K, Kantak SS, Murai M, Yao CC and
Kramer RH: Integrin α3β1 engagement disrupts intercellular
adhesion. Exp Cell Res. 262:180–196. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nurmenniemi S, Sinikumpu T, Alahuhta I,
Salo S, Sutinen M, Santala M, Risteli J, Nyberg P and Salo T: A
novel organotypic model mimics the tumor microenvironment. Am J
Pathol. 175:1281–1291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng
GQ, Wan XX, He QY, Li JH, Qu JQ, et al: Activation of EGFR promotes
squamous carcinoma SCC10A cell migration and invasion via inducing
EMT-like phenotype change and MMP-9-mediated degradation of
E-cadherin. J Cell Biochem. 112:2508–2517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng AL, Huang WG, Chen ZC, Peng F, Zhang
PF, Li MY, Li F, Li JL, Li C, Yi H, et al: Identification of novel
nasopharyngeal carcinoma biomarkers by laser capture
microdissection and proteomic analysis. Clin Cancer Res.
14:435–445. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang WG, Cheng AL, Chen ZC, Peng F, Zhang
PF, Li MY, Li F, Li JL, Li C, Yi H, et al: Targeted proteomic
analysis of 14-3-3σ in nasopharyngeal carcinoma. Int J Biochem Cell
Biol. 42:137–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu Z, Hung JH, Wang Y, Chang YC, Huang CL,
Huyck M and DeLisi C: VisANT 3.5: Multi-scale network
visualization, analysis and inference based on the gene ontology.
Nucleic Acids Res. 37:(Web Server). W115–W121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zuo J, Wen M, Lei M, Peng X, Yang X and
Liu Z: MiR-210 links hypoxia with cell proliferation regulation in
human Laryngocarcinoma cancer. J Cell Biochem. 116:1039–1049. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hardwick JM and Soane L: Multiple
functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol.
5:a0087222013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu L and Liu S: Autophagy contributes to
modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics.
Semin Cancer Biol. 23:553–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marquez RT and Xu L: Bcl-2:Beclin 1
complex: multiple, mechanisms regulating autophagy/apoptosis toggle
switch. Am J Cancer Res. 2:214–221. 2012.PubMed/NCBI
|
|
18
|
Karnak D and Xu L: Chemosensitization of
prostate cancer by modulating Bcl-2 family proteins. Curr Drug
Targets. 11:699–707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Buggins AG and Pepper CJ: The role of
Bcl-2 family proteins in chronic lymphocytic leukaemia. Leuk Res.
34:837–842. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mena S, Benlloch M, Ortega A, Carretero J,
Obrador E, Asensi M, Petschen I, Brown BD and Estrela JM: Bcl-2 and
glutathione depletion sensitizes B16 melanoma to combination
therapy and eliminates metastatic disease. Clin Cancer Res.
13:2658–2666. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie L, Qin W, Li J, He X, Zhang H, Yao G,
Shu H, Yao M, Wan D and Gu J: BNIPL-2 promotes the invasion and
metastasis of human hepatocellular carcinoma cells. Oncol Rep.
17:605–610. 2007.PubMed/NCBI
|
|
22
|
Planas-Silva MD, Bruggeman RD, Grenko RT
and Smith JS: Overexpression of c-Myc and Bcl-2 during progression
and distant metastasis of hormone-treated breast cancer. Exp Mol
Pathol. 82:85–90. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Olsson Åkefeldt S, Ismail MB, Valentin H,
Aricò M, Henter JI and Delprat C: Targeting BCL2 family in human
myeloid dendritic cells: A challenge to cure diseases with chronic
inflammations associated with bone loss. Clin Dev Immunol.
2013:7013052013.PubMed/NCBI
|
|
24
|
Hu Z, Snitkin ES and DeLisi C: VisANT: An
integrative framework for networks in systems biology. Brief
Bioinform. 9:317–325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu Z, Chang YC, Wang Y, Huang CL, Liu Y,
Tian F, Granger B and Delisi C: VisANT 4.0: Integrative network
platform to connect genes, drugs, diseases and therapies. Nucleic
Acids Res. 41:(Web Server). W225–W231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suderman M and Hallett M: Tools for
visually exploring biological networks. Bioinformatics.
23:2651–2659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hance MW, Nolan KD and Isaacs JS: The
double-edged sword: Conserved functions of extracellular hsp90 in
wound healing and cancer. Cancers (Basel). 6:1065–1097. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsaytler PA, Krijgsveld J, Goerdayal SS,
Rüdiger S and Egmond MR: Novel Hsp90 partners discovered using
complementary proteomic approaches. Cell Stress Chaperones.
14:629–638. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Calamia V, de Andrés MC, Oreiro N,
Ruiz-Romero C and Blanco FJ: Hsp90b inhibition modulates nitric
oxide production and nitric oxide-induced apoptosis in human
chondrocytes. BMC Musculoskelet Disord. 12:2372011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jia W, Yu C, Rahmani M, Krystal G,
Sausville EA, Dent P and Grant S: Synergistic antileukemic
interactions between 17-AAG and UCN-01 involve interruption of
RAF/MEK- and AKT-related pathways. Blood. 102:1824–1832. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan Z, Tardif G, Hum D, Duval N, Pelletier
JP and Martel-Pelletier J: Hsp90β and p130cas: Novel regulatory
factors of MMP-13 expression in human osteoarthritic chondrocytes.
Ann Rheum Dis. 68:976–982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J and Buchner J: Structure, function
and regulation of the hsp90 machinery. Biomed J. 36:106–117. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Whitesell L and Lin NU: HSP90 as a
platform for the assembly of more effective cancer chemotherapy.
Biochim Biophys Acta. 1823:756–766. 2012. View Article : Google Scholar : PubMed/NCBI
|
